View Full Page
Total Page:16
File Type:pdf, Size:1020Kb
The Journal of Neuroscience, August 15, 1999, 19(16):7230–7237 Rat Hippocampal Neurons Are Critically Involved in Physiological Improvement of Memory Processes Induced by Cholecystokinin-B Receptor Stimulation Ange´ lique Sebret,1 Isabelle Le´ na,1 Dominique Cre´te´,1 Toshimitsu Matsui,2 Bernard P. Roques,1 and Vale´ rie Dauge´ 1 1De´ partement de Pharmacochimie Mole´ culaire et Structurale, Institut National de la Sante´ et de la Recherche Me´ dicale U266, Centre National de la Recherche Scientifique, Unite´ Mixte de Recherche 8600, Unite´ de Formation et de Recherche des Sciences Pharmaceutiques et Biologiques, 75270 Paris Cedex 06, France, and 2Third Division Department of Medicine, Kobe University School of Medicine, Kobe 650–0017 Japan The involvement in memory processes of the neuropeptide the controls (2 hr time interval) when it was injected before the cholecystokinin (CCK) through its interaction with the CCK-B acquisition or the retrieval phase of the task. In addition, an receptors was studied. The two-trial recognition memory task increase of the extracellular levels of CCK-like immunoreactivity was used. Control animals showed recognition memory after a in the hippocampus of rats during the acquisition and retention 2 hr time interval but not aftera6hrtime interval between the phase of the task was observed. Finally, CCK-B receptor- two trials. The improving effect of a selective CCK-B agonist, deficient mice have an impairment of performance in the mem- BC 264, intraperitoneally administered (0.3 mg/kg) in the re- ory task (2 hr time interval). trieval phase of the task (6 hr time interval), was also observed Together, these results support the physiological involvement after its injection (1 pmol/0.5 ml) in the dorsal subiculum/CA1 of of the CCKergic system through its interaction with CCK-B the hippocampus but not in the caudate/putamen nucleus or in receptors in the hippocampus to improve performance of ro- the prefrontal cortex of rats. The CCK-B antagonist L-365,260 dents in the spatial recognition memory test. injected (10 ng/0.5 ml) into this region of the hippocampus abolished the improving effect of BC 264 injected intraperito- Key words: cholecystokinin-B receptors; spatial memory; neally. Furthermore, L-365,260 injected in the hippocampus CA1; prelimbic-infralimbic cortex; CCK release; CCK-B suppressed the recognition of the novel arm normally found in receptor-deficient mice The sulfated octapeptide cholecystokinin (CCK8 ) exerts its ef- Taghzouti et al., 1999). These effects were dependent on the fects through two G-protein-coupled receptors (Wank et al., dopaminergic (DAergic) system in the anterior part of the nu- 1992; Lee et al., 1993): CCK-B receptors are found essentially in cleus accumbens (N.Acc.) (Ladurelle et al., 1997). the CNS and CCK-A receptors are highly concentrated in the However, the systemic effects of BC 264 could not result from gastrointestinal tract but are also found in particular brain struc- a direct interaction between CCK-B receptors and DAergic ter- tures (Hill et al., 1987; Mercer and Beart, 1997). minals in the N.Acc., because opposite behavioral and biochem- Modulation of memory processes by the CCKergic system has ical responses were observed when this compound was locally been demonstrated in studies using, in most of them, active and injected in the anterior N.Acc. (Dauge´ et al., 1992; Ladurelle et passive avoidance tests (Katsuura and Itoh, 1986; for review, see al., 1993). This means that stimulation of CCK-B receptors local- Itoh and Lal, 1990; Dauge´ and Le´na, 1998). However, the role of ized in cerebral structures other than the N.Acc. could be respon- each receptor type and the physiological involvement of the sible of the effects occurring at this level. The neurons of the CCKergic system in memory processes remain poorly under- N.Acc. receive an intense DAergic innervation from the ventral stood. We have shown recently that systemic administration of tegmental area and glutamatergic projections from the hippocam- selective CCK-B agonists, such as BC 264 (Charpentier et al., pus, the prefrontal cortex, and the amygdala (Groenewegen et al., 1988), pBC 264 (Corringer et al., 1992), or RB400 (Million et al., 1991). Interestingly, anatomical data showed that CCKergic ter- 1997), improved the cognitive performances of rats measured in minals establish direct synaptic contact with glutamatergic neu- the spontaneous alternation test and a spatial two-trial memory rons of the hippocampus that project to the N.Acc. (Totterdell and task (Ladurelle et al., 1997; Million et al., 1997; Le´na et al., 1999; Smith, 1986), and BC 264 was shown to increase the glutamate and aspartate release and the firing rate of the CA1 neurons of the Received March 23, 1999; revised May 17, 1999; accepted May 20, 1999. hippocampus of rats (Dauge´ et al., 1990; Migaud et al., 1994). We thank H. Dhoˆtel for the synthesis of BC 264 and M. Beinfeld for a critical The present study was therefore designed to define the role of reading of this manuscript. brain structures, in particular the hippocampus and the prefrontal Correspondence should be addressed to Dr. Vale´rie Dauge´, De´partement de Pharmacochimie Mole´culaire et Structurale, Institut National de la Sante´etdela cortex, in the effects of BC 264 in a two-trial memory task in rats. Recherche Me´dicale U266, Centre National de la Recherche Scientifique, Unite´ This was achieved by local injection of BC 264 or the selective Mixte de Recherche 8600, Unite´ de Formation et de Recherche des Sciences Pharmaceutiques et Biologiques, 4, avenue de l’Observatoire, 75270 Paris Cedex 06, CCK-B antagonist L-365,260 (Chang and Lotti, 1986) in these France. structures. Furthermore, the physiological involvement of the Copyright © 1999 Society for Neuroscience 0270-6474/99/197230-08$05.00/0 CCKergic system in a spatial memory task was investigated using Sebret et al. • CCK-B Receptor Activation Improved Spatial Memory J. Neurosci., August 15, 1999, 19(16):7230–7237 7231 local injection of L-365,260 in the hippocampus of rats, by behav- beginning of each trial, but the position of the closed arm was alternated ioral analysis of mice with a deletion of CCK-B receptors (Nagata to the left or to the right of this arm, respectively, for half of the animals of each group tested. et al., 1996) and by quantification of the extracellular levels of In some local injection experiments with rats, the first and second CCK-like immunoreactivity (CCK-LIR) in the hippocampus by trials, which lasted 3 and 2 min, respectively, were separated bya6hr microdialysis in rat submitted or not to the memory task. time interval for which the control rats did not recognize the novel arm and explored the three arms equally (33.3% of visit duration in each arm). The time interval of 6 hr allowed the memory-improving effect of MATERIALS AND METHODS the drug to be studied, assessed by an increase in the exploration of the novel arm. Subjects In the other experiments, the trials were separated bya2hrtime Male Wistar rats (Charles River, Saint-Aubin les Elbeuf, France) weigh- interval for which the control rats spent more time exploring the novel ing 180–200 gm at the time of surgery were used. They were housed in arm. This time interval allowed the memory-impairment effect of the groups of four in a temperature-controlled (22 6 1°C) and humidity- drug to be studied. controlled (50 6 5%) environment and had access to food and water ad For microdialysis experiments, the two trials lasted 30 min because the libitum. Each animal was handled daily for 3 d before the experiments. samples were collected every 30 min. During the intertrial interval, rats CCK-B/gastrin receptor-deficient mice were provided from the origi- were put back in the microdialysis box. The trials were separated by a 2 nal background 129sv/C57BL6 mice (Nagata et al., 1996). Breeding and hr time interval. This time interval allowed changes in levels of CCK- genotype analysis have been done by Transgenic Alliance (L’Arbresle, LIR to be linked to the cognitive process. France). Twenty-five CCK-B receptor-deficient mice (13 males and 12 For mutant and wild-type mice, the task is the same as the previously females) and 26 mice (13 males and 13 females) of 129sv/C57BL6 genetic described one for the rats. The first and second trials, which lasted 3 and background (3 months old) were used. They were housed at least 1 week 2 min, respectively, were separated bya2hrtimeinterval for which before the experiments in the laboratory in a temperature-controlled control mice recognized and spent more time in the novel arm. (22 6 1°C) and humidity-controlled (50 6 5%) environment and had access to food and water ad libitum. The animals were treated as approved by the local committee and in Experimental procedure for local injections in the two-trial accordance with the NIH Guidelines for the Care and Use of Laboratory memory task in rats Animals (1985). Dorsal subiculum/CA1 of the hippocampus. In the dorsal subiculum/CA1 of the hippocampus, four series of experiments were done. Surgery The first consisted of a local injection of the CCK-B antagonist Rats were anesthetized by an intraperitoneal injection of chloral hydrate L-365,260 15 min after the intraperitoneal injection of the CCK-B (400 mg/kg), mounted in a stereotaxic apparatus (Unime´canique), and agonist BC 264. The agonist was administered 30 min before the second implanted bilaterally with 25-gauge stainless steel cannula guides (0.6 trial (i.e., the retrieval phase) aftera6hrintertrial interval. The follow- mm in external diameter) for local injection experiments.